Effects of grape seed extract on thalassemia major

Phase 2

Recruiting

• Conditions: Thalassemia major.; Beta thalassemia; D56.1

• Registration Number: IRCT20180603039959N2
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients affected by major thalassemia
Iron chelators consumption for at least 2 years
A history of iron chelator steady dose for the last 3 months
Having serum ferritin level more than 1000 µg/L
Patients with age limitation of 2 to 18 years old

Exclusion Criteria

Change in iron chelator therapy during the study (6 months)

Study & Design

• Study Type: interventional
• Study Design: Not specified